Advanced age a risk factor for illness temporally associated with yellow fever vaccination.

作者: Michael Martin , Leisa H Weld , Theodore F Tsai , Gina T Mootrey , Robert T Chen

DOI: 10.3201/EID0706.010605

关键词: VaccinationYellow fever vaccineYellow fever vaccinationData signalPediatricsRisk factorDisease controlAdverse effectMedicineYellow fever

摘要: In 1998, the Centers for Disease Control and Prevention was notified of severe illnesses one death, temporally associated with yellow fever (YF) vaccination, in two elderly U.S. residents. Because cases were unusual adverse events following YF vaccination had not been studied, we estimated age-related reporting rates systemic illness vaccination. We found that rate reported among vaccinees higher than 25 to 44 years age. also additional deaths vaccinees. These data signal a potential problem but are sufficient reliably estimate incidence or understand underlying mechanisms; therefore, enhanced surveillance is needed. remains an important cause travel disease-endemic regions increasing. For travelers, risk death due infection should be balanced against vaccine.

参考文章(36)
T.P. Monath, C. G. Hayes, West Nile fever. West Nile fever.. pp. 59- 88 ,(1989)
D. J. Vugia, S. B. Werner, M. E. Guroy, F. Schwartz, F. Drach, J. Olson, J. Rabban, H. Sanchez, M. S. Ascher, C. A. Glaser, Fatal yellow fever in a traveler returning from Venezuela, 1999. Morbidity and Mortality Weekly Report. ,vol. 49, pp. 303- 305 ,(2000)
Gerald L. Mandell, R. Gordon Douglas, John E. Bennett, Principles and Practice of Infectious Diseases ,(1985)
T P Monath, K Murphy, W G Downs, J D Poland, C H Calisher, Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine Bulletin of The World Health Organization. ,vol. 59, pp. 895- 900 ,(1981)
Joy M. McFarland, Larry M. Baddour, Jeffery E. Nelson, Sandra K. Elkins, Robert B. Craven, Bruce C. Cropp, Gwong‐Jen Chang, Alan D. Grindstaff, Allen S. Craig, Russell J. Smith, Imported yellow fever in a United States citizen Clinical Infectious Diseases. ,vol. 25, pp. 1143- 1147 ,(1997) , 10.1086/516111
David O Freedman, Phyllis E Kozarsky, Leisa H Weld, Martin S Cetron, Cetron for the GeoSentinel Group*, GeoSentinel: the global emerging infections sentinel network of the International Society of Travel Medicine. Journal of Travel Medicine. ,vol. 6, pp. 94- 98 ,(1999) , 10.1111/J.1708-8305.1999.TB00839.X
P. M. Strebel, R. W. Sutter, S. L. Cochi, R. J. Biellik, E. W. Brink, O. M. Kew, M. A. Pallansch, W. A. Orenstein, A. R. Hinman, Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated Disease Clinical Infectious Diseases. ,vol. 14, pp. 568- 579 ,(1992) , 10.1093/CLINIDS/14.2.568
Max Theiler, Hugh H. Smith, THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION Journal of Experimental Medicine. ,vol. 65, pp. 787- 800 ,(1937) , 10.1084/JEM.65.6.787
Bettina Temmesfeld-Wollbrück, Thomas Breuer, Manfred Dietel, Petra Emmerich, Herbert Schmitz, Norbert Suttorp, Dieter Teichmann, Martin P Grobusch, Hans Wesselmann, A haemorrhagic fever from the Côte d'lvoire The Lancet. ,vol. 354, pp. 1608- ,(1999) , 10.1016/S0140-6736(99)09233-8
Susan E. Robertson, Yellow Fever: A Decade of Reemergence JAMA. ,vol. 276, pp. 1157- 1162 ,(1996) , 10.1001/JAMA.1996.03540140045025